Meta Platforms (NASDAQ: META) has climbed 22% from its August low, buoyed by the launch of its Muse AI agent and a major legal settlement. The stock is on pace for its strongest monthly gain since May 2025, but analysts remain divided on whether this rally can hold.
Catalysts behind the rebound
The recovery accelerated after Meta settled a high-profile social-media lawsuit and introduced Muse, an AI tool designed to automate everyday tasks. These developments have revived the bull case for Meta, which has seen four separate rallies of at least 20% in 2026—each one fading and leaving the stock roughly flat for the year. By comparison, the Nasdaq 100 is up about 15%.
Meta shares were trading around $675 on Tuesday, up about 1.4%. Investors betting on a sustained breakout point to the removal of legal overhang and fresh AI momentum as reasons this time could be different.
"Eliminating a legal overhang and then having a positive product in a hot narrative is certainly enough to get the early stages of a trend change going," said Dan Russo, co-chief investment officer at Potomac Fund Management, which owns Meta shares. "What's key from here is to build on the momentum and validate the changing trend."
For Russo, validation would require Meta stock to break decisively above $700 and stay there. The $18 billion settlement, announced on Aug. 26, removed a risk that could have exposed Meta to penalties as high as $1.4 trillion. Since the settlement, Meta shares have fallen in only four of 12 trading sessions.
AI products strengthen the investment case
The legal resolution has coincided with renewed optimism about Meta's AI ambitions. Morgan Stanley analyst Brian Nowak draws a parallel to Alphabet's late-2025 rally, which followed a favorable antitrust ruling and a series of AI product launches. Alphabet shares have since gained more than 50%, becoming the best-performing Magnificent Seven stock.
Nowak believes Meta could follow a similar path. "Meta is in position to keep releasing new products, which in aggregate could add $10+ to EPS," he wrote in an Aug. 30 note, adding that these catalysts are not yet priced in. JPMorgan also turned more bullish, upgrading Meta to overweight last week, citing "strong early traction" for Muse and Meta's ability to deliver consumer AI to its roughly 4 billion users.
Valuation looks cheap, but spending looms
Meta trades at about 18 times forward earnings, below its 10-year average of 20 times and more than 30% below its 2025 peak. Analysts expect revenue growth of over 25% this year and earnings growth of over 30%.
However, the cheap valuation reflects concerns about Meta's massive AI spending. Capital expenditures are projected to nearly double to about $140 billion this year and reach almost $200 billion by 2027. That spending is expected to push free cash flow into negative territory—estimated at -$6.3 billion this year and potentially -$30 billion by 2027.
"The valuation is attractive, and it could have more short-term catalysts than megacaps, but for anything beyond that, all bets are off," said Cyrus Amini, chief investment officer at Hyphen Wealth Management. "Things are changing so fast it's hard to safely say any name is a long-term winner."
Investors are also watching broader AI sentiment, as seen in recent moves among AI-related stocks and AI safety warnings. The path to $700 will depend on whether Meta can sustain momentum and prove its AI investments pay off.
This article is for informational purposes only and does not constitute financial advice.
